Utkal Multispeciality Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 6.17%
- Ebitda 13.91%
- Net Worth -20.57%
- Total Assets -18.33%
About Utkal Multispeciality
Utkal Multispeciality Private Limited (UMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 December 2020 (Four years and two months 0 days old ). Its registered office is in Kendujhar, Odisha, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Atasi Das and Subhasish Das serve as directors at the Company.
Company Details
-
Location
Kendujhar, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100OR2020PTC034982
-
Company No.
034982
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Dec 2020
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Utkal Multispeciality?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atasi Das
|
Additional Director | 30-Oct-2021 | Current |
|
Subhasish Das
|
Director | 03-Dec-2020 | Current |
Financial Performance of Utkal Multispeciality.
Utkal Multispeciality Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Utkal Multispeciality?
Unlock access to Utkal Multispeciality's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ardent Steel Private LimitedSubhasish Das is a mutual person
-
Livcel Private LimitedAtasi Das is a mutual person
-
Odicel Ventures Private Limited
Atasi Das is a mutual person
-
Starstigma Private Limited
Atasi Das is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Utkal Multispeciality?
Utkal Multispeciality has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Utkal Multispeciality, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Utkal Multispeciality's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
